EVMN · Evommune, Inc.
Market Cap
$480.14M
Shares
36.29M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-07-30 | 2026-07-29 | |
| 8-K | 2026-06-29 | — | |
| Investor Event Transcript | 2026-06-02 | 2026-06-30 | |
| 8-K | 2026-06-02 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-21 | — | |
| 8-K | 2026-04-13 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2026-02-13 | 2026-02-12 | |
| 8-K | 2026-02-10 | — | |
| 8-K | 2025-12-11 | — | |
| 10-Q | 2025-12-11 | 2025-09-30 | |
| 8-K | 2025-11-07 | — |
Showing 1–17 of 17 filings
Key facts
CIK
2044725
CUSIP
30054Y107
13F (30d)
101 filings
100 filers
Visit website
Investor relations